Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA

被引:1
|
作者
Anouti, Ahmad [1 ]
Patel, Madhukar S. [2 ]
Vanwagner, Lisa B. [1 ]
Lee, William M. [1 ]
Asrani, Sumeet K. [3 ]
Mufti, Arjmand R. [1 ]
Rich, Nicole E. [1 ]
Vagefi, Parsia A. [2 ]
Shah, Jigesh A. [2 ]
Kerr, Thomas A. [1 ]
Pedersen, Mark [1 ]
Hanish, Steven [2 ]
Singal, Amit G. [1 ]
Cotter, Thomas G. [1 ,4 ]
机构
[1] UT Southwestern Med Ctr, Div Digest & Liver Dis, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] UT Southwestern Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
DISEASE SCORE; ADULT; AGE; IMPACT; LOBE; MODEL; RECIPIENTS; SAFETY; GRAFT;
D O I
10.1097/LVT.0000000000000228
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recent deceased-donor allocation changes in the United States may have increased high-Model for End-Stage Liver Disease (MELD) living donor liver transplantation (LDLT); however, outcomes in these patients remain poorly defined. We aimed to examine the impact of the MELD score on LDLT outcomes. Using UNOS data (January 1, 2010-December 31, 2021), LDLT recipients were identified and stratified into low-MELD (<15), intermediate-MELD (15-24), and high-MELD (=25) groups. We compared outcomes between MELD-stratified LDLT groups and between MELD-stratified LDLT and donation after brain death liver transplantation recipients. We used Kaplan-Meier analysis to compare graft survival rates and multivariable Cox proportional hazards modeling to identify factors associated with graft outcomes. Of 3558 LDLTs, 1605 (45.1%) were low-MELD, 1616 (45.4%) intermediate-MELD, and 337 (9.5%) high-MELD. Over the study period, the annual number of LDLTs increased from 282 to 569, and the proportion of high-MELD LDLTs increased from 3.9% to 7.7%. Graft survival was significantly higher in low-MELD versus high-MELD LDLT recipients (adjusted HR = 1.36, 95% CI: 1.03-1.79); however, 5-year survival exceeded 70.0% in both groups. We observed no significant difference in graft survival between high-MELD LDLT and high-MELD donation after brain death liver transplantation recipients (adjusted HR: 1.25, 95% CI:0.99-1.58), with a 5-year survival of 71.5% and 77.3%, respectively. Low LDLT center volume (<3 LDLTs/year) and recipient life support requirement were both associated with inferior graft outcomes among high-MELD LDLT recipients. While higher MELD scores confer graft failure risk in LDLT, high-MELD LDLT outcomes are acceptable with similar outcomes to MELD-stratified donation after brain death liver transplantation recipients. Future practice guidance should consider the expansion of LDLT recommendations to high-MELD recipients in centers with expertise to help reduce donor shortage.
引用
收藏
页码:72 / 82
页数:11
相关论文
共 50 条
  • [21] The Outcomes of Patients with Severe Hyperbilirubinemia Following Living Donor Liver Transplantation
    Matsushima, Hajime
    Soyama, Akihiko
    Takatsuki, Mitsuhisa
    Hidaka, Masaaki
    Muraoka, Izumi
    Kuroki, Tamotsu
    Eguchi, Susumu
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (05) : 1410 - 1414
  • [22] Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores
    Chok, Kenneth S. H.
    Chan, See Ching
    Fung, James Y. Y.
    Cheung, Tan To
    Chan, Albert C. Y.
    Fan, Sheung Tat
    Lo, Chung Mau
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (03) : 256 - 262
  • [23] Meta-analysis and meta-regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation
    Barbetta, Arianna
    Aljehani, Mayada
    Kim, Michelle
    Tien, Christine
    Ahearn, Aaron
    Schilperoort, Hannah
    Sher, Linda
    Emamaullee, Juliet
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (07) : 2399 - 2412
  • [24] Role of living donor liver transplantation in the treatment of hepatitis C virus infection
    Tsoulfas, Georgios
    Agorastou, Polyxeni
    HEPATITIS MONTHLY, 2011, 11 (06) : 427 - 433
  • [25] Clinical outcomes of patients with hepatorenal syndrome after living donor liver transplantation
    Lee, Jung Pyo
    Kwon, Hyuk Yong
    Park, Ji In
    Yi, Nam-Joon
    Suh, Kyung-Suk
    Lee, Hae Won
    Kim, Myounghee
    Oh, Yun Kyu
    Lim, Chun Soo
    Kim, Yon Su
    LIVER TRANSPLANTATION, 2012, 18 (10) : 1237 - 1243
  • [26] D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts
    Tanemura, A.
    Mizuno, S.
    Kato, H.
    Murata, Y.
    Kuriyama, N.
    Azumi, Y.
    Kishiwada, M.
    Usui, M.
    Sakurai, H.
    Isaji, S.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (04) : 1025 - 1031
  • [27] Short Term Donor Outcomes After Hepatectomy in Living Donor Liver Transplantation
    Dar, Faisal Saud
    Zia, Haseeb
    Bhatti, Abu Bakar Hafeez
    Rana, Atif
    Nazer, Rashid
    Kazmi, Rubab
    Khan, Etizaz-ud-Din
    Khan, Nasir Ayub
    Salih, Muhammad
    Shah, Najmul Hassan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (04): : 272 - 276
  • [29] Living Donor Liver Transplantation in South Asia: Single Center Experience on Intermediate-Term Outcomes
    Dar, Faisal S.
    Bhatti, Abu Bakar H.
    Qureshi, Ammal I.
    Khan, Nusrat Y.
    Eswani, Zahaan
    Zia, Haseeb H.
    Khan, Eitzaz U.
    Khan, Nasir A.
    Rana, Atif
    Shah, Najmul H.
    Salih, Mohammad
    Nazer, Rashid
    WORLD JOURNAL OF SURGERY, 2018, 42 (04) : 1111 - 1119
  • [30] Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA
    Nekrasov, Victor
    Matsuoka, Lea
    Kaur, Navpreet
    Pita, Alejandro
    Whang, Gilbert
    Cao, Shu
    Groshen, Susan
    Alexopoulos, Sophoclis
    TRANSPLANTATION, 2017, 101 (10) : 2360 - 2367